Sept 30 (Reuters) - Drugmaker Pfizer Inc raised its full-year revenue and adjusted profit forecast to reflect its recently closed deal for hospital products maker Hospira Inc.

Pfizer now expects 2015 revenue in the range of $46.5 billion to $47.5 billion, up from its previous estimate of $45.0 billion to $46.0 billion.

The drugmaker also raised both ends of its adjusted profit forecast by 3 cents, to $2.04-$2.10 per share.

(Reporting by Natalie Grover in Bengaluru; Editing by Shounak Dasgupta)